Metraipolis › archive › dc_bf73aceaeee1

A SARS-CoV-2 spike-derived adjuvant peptide boosts IL-17/IFN-γ immunity and improves anti-PD-L1 therapy against melanoma — Europe PMC PMID:41455906

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41455906
DOI: 10.1186/s10020-[numero omesso]-2
License (as archived): solo-consultazione
Archived: 2026-11-07T09:18:11.950Z
SHA-256 of the archived text: 40eae908a1b7b1d6e1bb72990a0b49de4c2365c432f40cc612895d5550f4d418
Stable URL of this page: https://metraipolis.com/documento/dc_bf73aceaeee1

How to cite

A SARS-CoV-2 spike-derived adjuvant peptide boosts IL-17/IFN-γ immunity and improves anti-PD-L1 therapy against melanoma — Europe PMC PMID:41455906 — Europe PMC (en), https://europepmc.org/article/MED/41455906 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf73aceaeee1 (Metraipolis archive dc_bf73aceaeee1, sha256 40eae908a1b7b1d6e1bb72990a0b49de4c2365c432f40cc612895d5550f4d418)

BibTeX

@misc{dcbf73aceaeee1,
  title = {A SARS-CoV-2 spike-derived adjuvant peptide boosts IL-17/IFN-γ immunity and improves anti-PD-L1 therapy against melanoma — Europe PMC PMID:41455906},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41455906},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf73aceaeee1; sha256 40eae908a1b7b1d6e1bb72990a0b49de4c2365c432f40cc612895d5550f4d418},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41455906. Agents can read the archived copy with the MCP tool read_document.